Drug intelligence / Profile preview

jingu wan

Development stage: Unknown
Lead developer: Liaoning Jindan Pharmaceutical
Administration: Oral

Overview

Jin Gu Wan is a traditional Chinese medicine (TCM) manufactured by Liaoning Jindan Pharmaceutical. It is an approved pharmaceutical product in China, primarily indicated for the treatment of rheumatic conditions, including joint pain, limb numbness, and musculoskeletal aches. The formulation is designed according to TCM principles to expel wind and cold, remove dampness, and promote blood circulation to alleviate pain. It is commonly used to manage symptoms associated with chronic arthritis and various forms of rheumatism. As a complex herbal mixture, it exerts its therapeutic effects through the synergistic action of multiple bioactive compounds that provide anti-inflammatory and analgesic properties.

Brand names: Jin Gu Wan
Other names: 筋骨丸

Beyond the preview

Go deeper on jingu wan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on jingu wan.

Explore the full profile